Pictet Asset Management (Switzerland)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$92.4M Buy
2,518,887
+103,611
+4% +$4.03M 0.11% 206
2023
Q1
$98.5M Sell
2,415,276
-713,924
-23% -$30.8M 0.12% 198
2022
Q4
$160M Buy
3,129,200
+132,500
+4% +$6.35M 0.23% 135
2022
Q3
$131M Sell
2,996,700
-40,479
-1% -$1.97M 0.19% 158
2022
Q2
$159M Sell
3,037,179
-90,907
-3% -$4.63M 0.22% 139
2022
Q1
$162M Buy
3,128,086
+42,256
+1% +$2.19M 0.18% 162
2021
Q4
$182M Sell
3,085,830
-108,691
-3% -$5.39M 0.18% 162
2021
Q3
$137M Buy
+3,194,521
New +$142M 0.15% 180

Other funds holding PFE

Pictet Asset Management (Switzerland)'s PFE Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Pfizer (PFE) stake by 4.3% in Q2 2023, buying an estimated $4.03M and bringing the position to 2,518,887 shares worth $92.4M. The position accounts for 0.11% of the portfolio, ranked #206.

Pictet Asset Management (Switzerland) first reported a position in PFE in Q3 2021 and has held it in 8 quarters since. The position peaked at $182M in Q4 2021. 3,042 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 2,518,887 shares of Pfizer worth $92.4M as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 103,611 Pfizer shares in Q2 2023, an estimated $4.03M.
  • Pfizer made up 0.11% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #206 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Pfizer in Q3 2021 and has held it in 8 quarters since.
  • Pictet Asset Management (Switzerland)'s Pfizer position peaked at $182M in Q4 2021.
  • 3,042 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.